Retinoids, Breast Cancer, and NK Cells
Author Information
Author(s): M.L. Villa, E. Ferrari, D. Trabattoni, F. Formelli, G. De Palo, A. Magni, U. Veronesi, E. Clerici
Primary Institution: Istituto Nazionale Tumori, Milano, Italy
Hypothesis
The study investigates the effect of the synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) on natural killer (NK) cell activity in breast cancer patients.
Conclusion
The study found that NK cell activity is significantly increased in women treated with 4-HPR compared to those receiving a placebo.
Supporting Evidence
- NK activity was augmented 1.73 times in 4-HPR treated women compared to placebo.
- Functional activity of NK cells increased, but their number did not change.
- IL-2 production was similar in both 4-HPR and placebo groups.
Takeaway
This study shows that a medicine called 4-HPR can help the body's natural defenses fight cancer better in women who had breast cancer surgery.
Methodology
The study involved a randomized phase III trial where 31 breast cancer women were treated with 200 mg of 4-HPR daily for 180 days, and their NK cell activity was measured.
Limitations
The study does not explore the long-term effects of 4-HPR beyond 180 days or its effects on different cancer types.
Participant Demographics
Participants were 31 breast cancer women aged 35-65 years with no axillary lymph node metastases.
Statistical Information
P-Value
<0.005
Statistical Significance
p<0.005
Want to read the original?
Access the complete publication on the publisher's website